 | • レポートコード：MRC2012A5067 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インスリングラルギンの世界市場を広く調査・分析し、今後の市場展望をまとめております。インスリングラルギンの種類別市場規模（単回投与バイアル、プレフィルドシリンジ）、用途別市場規模（2型糖尿病治療、1型糖尿病治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi-Aventis、Ganlee、Biocon、 ・地域別グローバル市場分析 2015年-2020年 ・インスリングラルギンの北米市場（アメリカ、カナダ、メキシコ） ・インスリングラルギンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インスリングラルギンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インスリングラルギンの南米市場（ブラジル、アルゼンチン） ・インスリングラルギンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：単回投与バイアル、プレフィルドシリンジ ・用途別分析：2型糖尿病治療、1型糖尿病治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Insulin Glargine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Insulin Glargine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 7383.1 million by 2025, from USD 6353 million in 2019.
Market segmentation
Insulin Glargine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insulin Glargine market has been segmented into
Single Dose Vial
Pre-filled Syringe
By Application, Insulin Glargine has been segmented into:
Treat type2 diabetes
Treat type1 diabetes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insulin Glargine market presented in the report. This section sheds light on the sales growth of different regional and country-level Insulin Glargine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insulin Glargine market.
The report offers in-depth assessment of the growth and other aspects of the Insulin Glargine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Insulin Glargine Market Share Analysis
Insulin Glargine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insulin Glargine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insulin Glargine sales, revenue and market share for each player covered in this report.
The major players covered in Insulin Glargine are:
Sanofi-Aventis
Ganlee
Biocon
Among other players domestic and global, Insulin Glargine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Glargine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Glargine, with price, sales, revenue and global market share of Insulin Glargine in 2018 and 2019.
Chapter 3, the Insulin Glargine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Glargine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Insulin Glargine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Insulin Glargine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Glargine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Glargine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Treat type2 diabetes
1.3.3 Treat type1 diabetes
1.4 Overview of Global Insulin Glargine Market
1.4.1 Global Insulin Glargine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Sanofi-Aventis Details
2.1.2 Sanofi-Aventis Major Business
2.1.3 Sanofi-Aventis SWOT Analysis
2.1.4 Sanofi-Aventis Product and Services
2.1.5 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ganlee
2.2.1 Ganlee Details
2.2.2 Ganlee Major Business
2.2.3 Ganlee SWOT Analysis
2.2.4 Ganlee Product and Services
2.2.5 Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon SWOT Analysis
2.3.4 Biocon Product and Services
2.3.5 Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Insulin Glargine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Insulin Glargine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Glargine Manufacturer Market Share in 2019
3.3.2 Top 6 Insulin Glargine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Insulin Glargine Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Glargine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Insulin Glargine Revenue and Market Share by Regions (2015-2020)
4.2 North America Insulin Glargine Sales and Growth Rate (2015-2020)
4.3 Europe Insulin Glargine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Insulin Glargine Sales and Growth Rate (2015-2020)
4.5 South America Insulin Glargine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Insulin Glargine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Insulin Glargine Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Glargine Sales and Market Share by Country (2015-2020)
5.1.2 North America Insulin Glargine Revenue and Market Share by Country (2015-2020)
5.2 United States Insulin Glargine Sales and Growth Rate (2015-2020)
5.3 Canada Insulin Glargine Sales and Growth Rate (2015-2020)
5.4 Mexico Insulin Glargine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Insulin Glargine Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Glargine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Insulin Glargine Revenue and Market Share by Country (2015-2020)
6.2 Germany Insulin Glargine Sales and Growth Rate (2015-2020)
6.3 UK Insulin Glargine Sales and Growth Rate (2015-2020)
6.4 France Insulin Glargine Sales and Growth Rate (2015-2020)
6.5 Russia Insulin Glargine Sales and Growth Rate (2015-2020)
6.6 Italy Insulin Glargine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Insulin Glargine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Insulin Glargine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Insulin Glargine Revenue and Market Share by Regions (2015-2020)
7.2 China Insulin Glargine Sales and Growth Rate (2015-2020)
7.3 Japan Insulin Glargine Sales and Growth Rate (2015-2020)
7.4 Korea Insulin Glargine Sales and Growth Rate (2015-2020)
7.5 India Insulin Glargine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Insulin Glargine Sales and Growth Rate (2015-2020)
7.7 Australia Insulin Glargine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Insulin Glargine Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Glargine Sales and Market Share by Country (2015-2020)
8.1.2 South America Insulin Glargine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Insulin Glargine Sales and Growth Rate (2015-2020)
8.3 Argentina Insulin Glargine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Insulin Glargine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Insulin Glargine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Insulin Glargine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Insulin Glargine Sales and Growth Rate (2015-2020)
9.3 Turkey Insulin Glargine Sales and Growth Rate (2015-2020)
9.4 Egypt Insulin Glargine Sales and Growth Rate (2015-2020)
9.5 South Africa Insulin Glargine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Insulin Glargine Sales and Market Share by Type (2015-2020)
10.2 Global Insulin Glargine Revenue and Market Share by Type (2015-2020)
10.3 Global Insulin Glargine Price by Type (2015-2020)
11 Global Insulin Glargine Market Segment by Application
11.1 Global Insulin Glargine Sales Market Share by Application (2015-2020)
11.2 Global Insulin Glargine Revenue Market Share by Application (2015-2020)
11.3 Global Insulin Glargine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Insulin Glargine Sales, Revenue and Growth Rate (2021-2025)
12.2 Insulin Glargine Market Forecast by Regions (2021-2025)
12.2.1 North America Insulin Glargine Market Forecast (2021-2025)
12.2.2 Europe Insulin Glargine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Insulin Glargine Market Forecast (2021-2025)
12.2.4 South America Insulin Glargine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Insulin Glargine Market Forecast (2021-2025)
12.3 Insulin Glargine Market Forecast by Type (2021-2025)
12.3.1 Global Insulin Glargine Sales Forecast by Type (2021-2025)
12.3.2 Global Insulin Glargine Market Share Forecast by Type (2021-2025)
12.4 Insulin Glargine Market Forecast by Application (2021-2025)
12.4.1 Global Insulin Glargine Sales Forecast by Application (2021-2025)
12.4.2 Global Insulin Glargine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Insulin Glargine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insulin Glargine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Insulin Glargine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Aventis Insulin Glargine Major Business
Table 10. Sanofi-Aventis Insulin Glargine Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi-Aventis SWOT Analysis
Table 12. Sanofi-Aventis Insulin Glargine Product and Services
Table 13. Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Ganlee Basic Information, Manufacturing Base and Competitors
Table 15. Ganlee Insulin Glargine Major Business
Table 16. Ganlee Insulin Glargine Total Revenue (USD Million) (2018-2019)
Table 17. Ganlee SWOT Analysis
Table 18. Ganlee Insulin Glargine Product and Services
Table 19. Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Biocon Basic Information, Manufacturing Base and Competitors
Table 21. Biocon Insulin Glargine Major Business
Table 22. Biocon Insulin Glargine Total Revenue (USD Million) (2018-2019)
Table 23. Biocon SWOT Analysis
Table 24. Biocon Insulin Glargine Product and Services
Table 25. Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Global Insulin Glargine Sales by Manufacturer (2018-2019) (M mL)
Table 27. Global Insulin Glargine Revenue by Manufacturer (2018-2019) (USD Million)
Table 28. Global Insulin Glargine Sales by Regions (2015-2020) (M mL)
Table 29. Global Insulin Glargine Sales Market Share by Regions (2015-2020)
Table 30. Global Insulin Glargine Revenue by Regions (2015-2020) (USD Million)
Table 31. North America Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 32. North America Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 33. North America Insulin Glargine Revenue by Countries (2015-2020) (USD Million)
Table 34. North America Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 35. Europe Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 36. Europe Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 37. Europe Insulin Glargine Revenue by Countries (2015-2020) (USD Million)
Table 38. Asia-Pacific Insulin Glargine Sales by Regions (2015-2020) (M mL)
Table 39. Asia-Pacific Insulin Glargine Sales Market Share by Regions (2015-2020)
Table 40. Asia-Pacific Insulin Glargine Revenue by Regions (2015-2020) (USD Million)
Table 41. South America Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 42. South America Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 43. South America Insulin Glargine Revenue by Countries (2015-2020) (USD Million)
Table 44. South America Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 45. Middle East & Africa Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 46. Middle East & Africa Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 47. Middle East & Africa Insulin Glargine Revenue by Countries (2015-2020) (USD Million)
Table 48. Middle East & Africa Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 49. Global Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 50. Global Insulin Glargine Sales Share by Type (2015-2020)
Table 51. Global Insulin Glargine Revenue by Type (2015-2020) (USD Million)
Table 52. Global Insulin Glargine Revenue Share by Type (2015-2020)
Table 53. Global Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 54. Global Insulin Glargine Sales Share by Application (2015-2020)
Table 55. Global Insulin Glargine Sales Forecast by Regions (2021-2025) (M mL)
Table 56. Global Insulin Glargine Market Share Forecast by Regions (2021-2025)
Table 57. Global Insulin Glargine Sales Forecast by Type (2021-2025) (M mL)
Table 58. Global Insulin Glargine Market Share Forecast by Type (2021-2025)
Table 59. Global Insulin Glargine Sales Forecast by Application (2021-2025)
Table 60. Global Insulin Glargine Market Share Forecast by Application (2021-2025)
Table 61. Direct Channel Pros & Cons
Table 62. Indirect Channel Pros & Cons
Table 63. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Insulin Glargine Picture
Figure 2. Global Sales Market Share of Insulin Glargine by Type in 2019
Figure 3. Single Dose Vial Picture
Figure 4. Pre-filled Syringe Picture
Figure 5. Insulin Glargine Sales Market Share by Application in 2019
Figure 6. Treat type2 diabetes Picture
Figure 7. Treat type1 diabetes Picture
Figure 8. Global Insulin Glargine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Insulin Glargine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Insulin Glargine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Insulin Glargine Sales Market Share by Manufacturer in 2019
Figure 29. Global Insulin Glargine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Insulin Glargine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Insulin Glargine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 34. Global Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Insulin Glargine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Insulin Glargine Revenue Market Share by Regions in 2018
Figure 37. North America Insulin Glargine Sales and Growth Rate (2015-2020)
Figure 38. Europe Insulin Glargine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Insulin Glargine Sales and Growth Rate (2015-2020)
Figure 40. South America Insulin Glargine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Insulin Glargine Sales and Growth Rate (2015-2020)
Figure 42. North America Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Insulin Glargine Sales Market Share by Countries (2015-2020)
Figure 44. North America Insulin Glargine Sales Market Share by Countries in 2018
Figure 45. North America Insulin Glargine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Insulin Glargine Revenue Market Share by Countries in 2018
Figure 47. United States Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 48. Canada Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 49. Mexico Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 50. Europe Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Insulin Glargine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Insulin Glargine Revenue Market Share by Countries in 2019
Figure 53. Germany Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 54. UK Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 55. France Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 56. Russia Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 57. Italy Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 58. Asia-Pacific Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Insulin Glargine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Insulin Glargine Revenue Market Share by Regions 2019
Figure 61. China Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 62. Japan Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 63. Korea Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 64. India Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 65. Southeast Asia Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 66. South America Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Insulin Glargine Sales Market Share by Countries in 2019
Figure 68. South America Insulin Glargine Revenue Market Share by Countries in 2019
Figure 69. Brazil Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 70. Argentina Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 71. Middle East and Africa Insulin Glargine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Insulin Glargine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Insulin Glargine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Insulin Glargine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 76. Egypt Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 77. Turkey Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 78. South Africa Insulin Glargine Sales and Growth Rate (2015-2020) (M mL)
Figure 79. Global Insulin Glargine Sales and Growth Rate (2021-2025) (M mL)
Figure 80. Global Insulin Glargine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Insulin Glargine Market Forecast (2021-2025) (M mL)
Figure 82. Europe Sales Insulin Glargine Market Forecast (2021-2025) (M mL)
Figure 83. Asia-Pacific Sales Insulin Glargine Market Forecast (2021-2025) (M mL)
Figure 84. South America Sales Insulin Glargine Market Forecast (2021-2025) (M mL)
Figure 85. Middle East & Africa Sales Insulin Glargine Market Forecast (2021-2025) (M mL)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- インスリンリスプロの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Insulin Lispro market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 自動インスリンデリバリーシステムの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Automated Insulin Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…